{"id":878,"date":"2016-11-17T13:28:13","date_gmt":"2016-11-17T12:28:13","guid":{"rendered":"https:\/\/staging.blogs.yokogawa.de\/chemical-pharma\/uncategorized\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/"},"modified":"2022-07-04T06:59:21","modified_gmt":"2022-07-04T04:59:21","slug":"namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist","status":"publish","type":"post","link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/","title":{"rendered":"NAMUR-Keynote: MD Germany Helget discloses that having the right technology is not enough"},"content":{"rendered":"<p>It is the combination of processes, technology and experts which make Yokogawa special. Exciting examples which prove that will be explained by Helget. Learn further in this video, which indicators influences Yokogawas success.<\/p>\n<p>What do you think about Yokogawa?<\/p>\n<p>Leave a comment.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>It is the combination of processes, technology and experts which make Yokogawa special. Exciting examples which prove that will be explained by Helget. Learn further in this video, which indicators influences Yokogawas success. What do you think about Yokogawa? Leave&hellip; <\/p>\n<p class=\"read-more\"> <a class=\"\" href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/\"> <span class=\"screen-reader-text\">NAMUR-Keynote: MD Germany Helget discloses that having the right technology is not enough<\/span> Read More &raquo;<\/a><\/p>\n","protected":false},"author":31,"featured_media":879,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"","footnotes":""},"categories":[54],"tags":[],"coauthors":[80,81],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.13 (Yoast SEO v20.13) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>NAMUR-Keynote: MD Germany Helget discloses that having the right technology is not enough - Chemical Pharma Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NAMUR-Keynote: MD Germany Helget discloses that having the right technology is not enough\" \/>\n<meta property=\"og:description\" content=\"It is the combination of processes, technology and experts which make Yokogawa special. Exciting examples which prove that will be explained by Helget. Learn further in this video, which indicators influences Yokogawas success. What do you think about Yokogawa? Leave&hellip;  NAMUR-Keynote: MD Germany Helget discloses that having the right technology is not enough Read More &raquo;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/\" \/>\n<meta property=\"og:site_name\" content=\"Chemical Pharma Blog\" \/>\n<meta property=\"article:published_time\" content=\"2016-11-17T12:28:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-04T04:59:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/054-NAMUR-YOKOGAWA-2016-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Niklas Frielingsdorf\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/\"},\"author\":{\"name\":\"Niklas Frielingsdorf\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/f29c6dea0d8cefb06eba3da6979c681f\"},\"headline\":\"NAMUR-Keynote: MD Germany Helget discloses that having the right technology is not enough\",\"datePublished\":\"2016-11-17T12:28:13+00:00\",\"dateModified\":\"2022-07-04T04:59:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/\"},\"wordCount\":56,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization\"},\"articleSection\":[\"Corporate\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/\",\"name\":\"NAMUR-Keynote: MD Germany Helget discloses that having the right technology is not enough - Chemical Pharma Blog\",\"isPartOf\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#website\"},\"datePublished\":\"2016-11-17T12:28:13+00:00\",\"dateModified\":\"2022-07-04T04:59:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NAMUR-Keynote: MD Germany Helget discloses that having the right technology is not enough\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#website\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/\",\"name\":\"Chemical Pharma Blog\",\"description\":\"Yokogawa&#039;s Chemical &amp; Pharma Blog\",\"publisher\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization\",\"name\":\"Chemical Pharma Blog\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png\",\"contentUrl\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png\",\"width\":302,\"height\":89,\"caption\":\"Chemical Pharma Blog\"},\"image\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/f29c6dea0d8cefb06eba3da6979c681f\",\"name\":\"Niklas Frielingsdorf\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/image\/26bfbff9ac7a54d6fe4079add1304bdc\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e31ded97b5d09566514531c6356737ce?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e31ded97b5d09566514531c6356737ce?s=96&d=mm&r=g\",\"caption\":\"Niklas Frielingsdorf\"},\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/author\/niklas-frielingsdorf\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"NAMUR-Keynote: MD Germany Helget discloses that having the right technology is not enough - Chemical Pharma Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/","og_locale":"en_US","og_type":"article","og_title":"NAMUR-Keynote: MD Germany Helget discloses that having the right technology is not enough","og_description":"It is the combination of processes, technology and experts which make Yokogawa special. Exciting examples which prove that will be explained by Helget. Learn further in this video, which indicators influences Yokogawas success. What do you think about Yokogawa? Leave&hellip;  NAMUR-Keynote: MD Germany Helget discloses that having the right technology is not enough Read More &raquo;","og_url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/","og_site_name":"Chemical Pharma Blog","article_published_time":"2016-11-17T12:28:13+00:00","article_modified_time":"2022-07-04T04:59:21+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/054-NAMUR-YOKOGAWA-2016-scaled.jpg","type":"image\/jpeg"}],"author":"Niklas Frielingsdorf","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/#article","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/"},"author":{"name":"Niklas Frielingsdorf","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/f29c6dea0d8cefb06eba3da6979c681f"},"headline":"NAMUR-Keynote: MD Germany Helget discloses that having the right technology is not enough","datePublished":"2016-11-17T12:28:13+00:00","dateModified":"2022-07-04T04:59:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/"},"wordCount":56,"commentCount":0,"publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization"},"articleSection":["Corporate"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/","name":"NAMUR-Keynote: MD Germany Helget discloses that having the right technology is not enough - Chemical Pharma Blog","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#website"},"datePublished":"2016-11-17T12:28:13+00:00","dateModified":"2022-07-04T04:59:21+00:00","breadcrumb":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/namur-keynote-md-deutschland-helget-enthuellt-warum-die-richtige-technologie-nicht-alles-ist\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/"},{"@type":"ListItem","position":2,"name":"NAMUR-Keynote: MD Germany Helget discloses that having the right technology is not enough"}]},{"@type":"WebSite","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#website","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/","name":"Chemical Pharma Blog","description":"Yokogawa&#039;s Chemical &amp; Pharma Blog","publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization","name":"Chemical Pharma Blog","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","contentUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","width":302,"height":89,"caption":"Chemical Pharma Blog"},"image":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/f29c6dea0d8cefb06eba3da6979c681f","name":"Niklas Frielingsdorf","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/image\/26bfbff9ac7a54d6fe4079add1304bdc","url":"https:\/\/secure.gravatar.com\/avatar\/e31ded97b5d09566514531c6356737ce?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e31ded97b5d09566514531c6356737ce?s=96&d=mm&r=g","caption":"Niklas Frielingsdorf"},"url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/author\/niklas-frielingsdorf\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/054-NAMUR-YOKOGAWA-2016-scaled.jpg",2560,1707,false],"thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/054-NAMUR-YOKOGAWA-2016-150x150.jpg",150,150,true],"medium":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/054-NAMUR-YOKOGAWA-2016-300x200.jpg",300,200,true],"medium_large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/054-NAMUR-YOKOGAWA-2016-768x512.jpg",768,512,true],"large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/054-NAMUR-YOKOGAWA-2016-1024x683.jpg",1024,683,true],"1536x1536":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/054-NAMUR-YOKOGAWA-2016-1536x1024.jpg",1536,1024,true],"2048x2048":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/054-NAMUR-YOKOGAWA-2016-2048x1365.jpg",2048,1365,true],"post-thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/054-NAMUR-YOKOGAWA-2016-356x200.jpg",356,200,true]},"uagb_author_info":{"display_name":"Niklas Frielingsdorf","author_link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/author\/niklas-frielingsdorf\/"},"uagb_comment_info":0,"uagb_excerpt":"It is the combination of processes, technology and experts which make Yokogawa special. Exciting examples which prove that will be explained by Helget. Learn further in this video, which indicators influences Yokogawas success. What do you think about Yokogawa? Leave&hellip; NAMUR-Keynote: MD Germany Helget discloses that having the right technology is not enough Read More&hellip;","_links":{"self":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/posts\/878"}],"collection":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/users\/31"}],"replies":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/comments?post=878"}],"version-history":[{"count":3,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/posts\/878\/revisions"}],"predecessor-version":[{"id":11385,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/posts\/878\/revisions\/11385"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/media\/879"}],"wp:attachment":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/media?parent=878"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/categories?post=878"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/tags?post=878"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/coauthors?post=878"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}